Drugs / Bupevecaine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT02708459 Comparator | Mar → Aug 2016 | — | AlRefaey Kandeel | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Bupevecaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02708459 ↗ |
| Route | Other | “20 ml Bupevecaine (0.25%) boluses in surgically inserted TAP catheter each 8 hours for 48 hours” NCT02708459 ↗ |